BioMed Technologies (BioMed Tec) is a medical (bio-sciences) research and development firm involved in the finance and promulgation of research and development of new medicines, new technologies and new ways to diagnose and treat terminal diseases.
From the development of products that enable the continuum of sustainable health, to nutritional products and pharmaceutical therapies, BioMed Technologies prides itself on being on the cutting edge of new technology with the goal of producing pharmaceuticals for human clinical trials, supporting drug discovery and development for terminal & infectious tropical diseases.
Whether its Heart Disease, Stroke, Diabetes, Cancer, Alzheimer's Disease, Parkinson's Disease or Influenza, our research and development of solutions to these chronic illnesses that cost millions of lives worldwide and billions of dollars in treatment regimen. We believe there is a cure...for all of it.
BioMed Technologies has sought to tap the power of scientific discovery and innovation to advance the practice of medicine and dramatically improve the quality of live for the terminally ill. We will not accept that a solution is not possible.
BioMed Tech is focused on pioneering the development of novel products based on advances in medical research through DNA and molecular biology, nano-technology and stem cell technology. Today, BioMed Technologies continues to be an entrepreneurial, science-driven company dedicated to fighting serious illness and seeks to find a cure for all ailments and advance wellness.
We have also ventured into seeking solutions to hair-loss,
aging, female menstrual solutions and male vitality & virility. Our goal is to assist in prolonging live, health and wellness and enhance the longevity of those capable of advancing humans here on earth and for space travel.
Dana-Farber | Sloan Kettering Cancer Center
Stem Cell Research
Stem Cell Banking | Immunotherapy
Mayo Clinic | John Hopkins
American Diabetes Association | DRI | Joslin
Zymo | Tgen | Claritas | Avera
alz.org | Bright Focus Foundation
Abacus | LexaGene | MacroGenics | Aperiomics
Teva | Ceregene | Valeant
Years in R&D
Core Focus Areas
BioMT provides physicians and medical centers with access to state-of-the-art diagnostic scanning equipment that allows for early detection of various ailments & life-threatening diseases, including leveraging body measurements to calculate body fat % with incredibly high precision using 3D modelling correlated to obesity related diseases, which doctors use to assess and stratify risk to patient health & longevity.
BioMT distributes a fully integrated non-invasive diagnostic device which performs comprehensive neuropathic
cardiovascular diagnostics, with a footprint small enough to fit in any physicians office. The Device is FDA Approved and is designed to identify numerous Health Risk factors at an early stage
Need to Know More?
BioMT distributes diagnostic scanners that can provide detection of any abnormalities within the body from the shoulders to the thighs. Whether it's the heart’s state of health, detecting lung cancer, emphysema, and other lung ailments or a virtual colonoscopy, these highly advances scanners are literally life savers.
Need to Know More?
PET/CT scans, to diagnose cancer; Fluoride (F18) Bone Scan, to diagnose bone metastases in cancer patients; nuclear whole body bone scan to evaluate various bone-related pathology, such as bone pain, stress fracture, nonmalignant bone lesions, bone infections, or the spread of cancer to the bone and other scans for the lungs, liver and gallbladder.
Need to Know More?
Monday – Friday 09:00AM – 19:00PM